- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bilirubin–Lipid Ratios May Predict Better Renal Outcomes in IgA Nephropathy: Study

A new study published in the journal of Frontiers in Endocrinology showed that increased levels of bilirubin when compared to lipids, especially the ratio of total bilirubin to total cholesterol (TBIL/TC), were linked to a reduced risk of negative kidney outcomes and improved maintenance of kidney function in individuals with IgA nephropathy (IgAN).
There is a requirement for dependable prognostic indicators for IgA nephropathy, a prevalent glomerular condition that often leads to end-stage renal disease (ESRD). Based on the antioxidant properties of bilirubin and the pro-inflammatory effects of dyslipidemia, researchers theorized that the ratio between total bilirubin and lipids could function as innovative combined biomarkers linked to kidney outcomes in IgAN.
This research assessed the effectiveness of four different ratios of bilirubin to lipids in the serum (TBIL/Triglyceride, TBIL/Cholesterol, TBIL/HDL, TBIL/LDL) by employing Cox regression, restricted cubic spline (RCS), and linear mixed-effects (LME) models in individuals diagnosed with IgAN through biopsy. 283 out of 1352 patients (20.93%) experienced a combined renal outcome (≥30% reduction in estimated glomerular filtration rate [eGFR] or end-stage renal disease [ESRD]).
According to the multivariable Cox analysis, all four ratios were individually linked to a decreased risk of this outcome: TBIL/Triglyceride (HR = 0.972, P = 0.025), TBIL/Cholesterol (HR = 0.849, P = 0.003), TBIL/HDL (HR = 0.970, P = 0.030), and TBIL/LDL (HR = 0.926, P = 0.004).
Despite the violation of the proportional hazards assumption (all P < 0.05), subsequent time-dependent and piecewise Cox models confirmed that the protective effects were significant in the initial phase (≤3.13 years) but diminished later on.
Analysis using restricted cubic splines (RCS) revealed direct linear connections for TBIL/Triglyceride, TBIL/Cholesterol, and TBIL/HDL, while TBIL/LDL displayed a pattern of threshold-saturation. These relationships were more evident in individuals with advanced tubulointerstitial lesions (Oxford T1/T2).
Longitudinal mixed effects (LME) models indicated that all four ratios were linked to higher eGFR levels over time (TBIL/Triglyceride: Estimate = 0.318, P = 0.002; TBIL/Cholesterol: Estimate = 1.242, P = 0.004; TBIL/HDL: Estimate = 0.289, P = 0.007; TBIL/LDL: Estimate = 0.446, P = 0.031), with these associations remaining consistent throughout the follow-up period.
Overall, elevated serum bilirubin-lipid ratios, specifically TBIL/Cholesterol, were found to be linked to a reduced likelihood of negative renal consequences and enhanced maintenance of renal function over time in individuals with IgAN. These results indicate that bilirubin-lipid ratios could offer additional predictive value beyond standard clinical and pathological markers, potentially enhancing risk assessment in this particular group.
Source:
Wang, S., Chen, Y., Zhou, H., Dong, L., Tang, Y., Tan, J., & Qin, W. (2026). Prognostic value of serum total bilirubin-lipid ratios in patients with IgA nephropathy. Frontiers in Endocrinology, 17(1898387), 1898387. https://doi.org/10.3389/fendo.2026.1898387
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

